TPG Inc. is working with bankers at JPMorgan Chase & Co. to explore the potential sale of Lyric, a healthcare payments software firm, according to a report from Reuters.
The potential transaction value for Lyric is estimated at $5 billion, as cited by sources familiar with the matter.
The report indicates that the process is in the early stages and that no final decisions have been made regarding a sale.
